Quantum Financial Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12M Buy
123,915
+95,962
+343% +$2.42M 0.31% 47
2026
Q1
$706K Sell
27,953
-53,557
-66% -$1.37M 0.08% 89
2025
Q4
$2.08M Buy
81,510
+12,508
+18% +$320K 0.23% 54
2025
Q3
$1.77M Buy
69,002
+2,356
+4% +$59.8K 0.22% 57
2025
Q2
$1.69M Buy
66,646
+3,093
+5% +$76.7K 0.23% 58
2025
Q1
$1.59M Buy
63,553
+521
+0.8% +$12.9K 0.24% 56
2024
Q4
$1.55M Buy
63,032
+1,123
+2% +$28.1K 0.24% 54
2024
Q3
$1.59M Buy
61,909
+6,175
+11% +$156K 0.25% 52
2024
Q2
$1.37M Buy
55,734
+2,008
+4% +$49K 0.24% 55
2024
Q1
$1.33M Buy
+53,726
New +$1.33M 0.25% 54

Other funds holding IBDX

Quantum Financial Advisors's IBDX Position: Q2 2026 in Review

Quantum Financial Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 343% in Q2 2026, buying an estimated $2.42M and bringing the position to 123,915 shares worth $3.12M. The position accounts for 0.31% of the portfolio, ranked #47.

Quantum Financial Advisors first reported a position in IBDX in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Quantum Financial Advisors held 123,915 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $3.12M as of Q2 2026.
  • Quantum Financial Advisors bought 95,962 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $2.42M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.31% of Quantum Financial Advisors's portfolio in Q2 2026, its #47 holding.
  • Quantum Financial Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Quantum Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.